BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Queensland Health
Dow
Chinese Patent Office
Deloitte
Farmers Insurance
UBS
Cantor Fitzgerald
McKinsey

Generated: January 19, 2018

DrugPatentWatch Database Preview

GLIMEPIRIDE Drug Profile

« Back to Dashboard

When do Glimepiride patents expire, and when can generic versions of Glimepiride launch?

Glimepiride is a drug marketed by Accord Hlthcare, Actavis Labs Fl Inc, Aurobindo Pharma Ltd, Carlsbad, Dr Reddys Labs Ltd, Epic Pharma Llc, Hikma Pharms, Indoco Remedies, Invagen Pharms, Micro Labs Ltd India, Mylan, Prinston Inc, Ranbaxy, Ranbaxy Labs Ltd, Teva, and Watson Labs. and is included in seventeen NDAs.

The generic ingredient in GLIMEPIRIDE is glimepiride. There are fifteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the glimepiride profile page.
Drug patent expirations by year for GLIMEPIRIDE
Pharmacology for GLIMEPIRIDE
Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea

US Patents and Regulatory Information for GLIMEPIRIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Prinston Inc GLIMEPIRIDE glimepiride TABLET;ORAL 077370-002 Dec 23, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Micro Labs Ltd India GLIMEPIRIDE glimepiride TABLET;ORAL 091220-005 Jun 29, 2012 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy Labs Ltd GLIMEPIRIDE glimepiride TABLET;ORAL 076875-004 Oct 6, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ranbaxy GLIMEPIRIDE glimepiride TABLET;ORAL 077366-002 Oct 6, 2005 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva GLIMEPIRIDE glimepiride TABLET;ORAL 076802-001 Oct 6, 2005 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs GLIMEPIRIDE glimepiride TABLET;ORAL 077280-003 Feb 3, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Micro Labs Ltd India GLIMEPIRIDE glimepiride TABLET;ORAL 091220-001 Jun 29, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Micro Labs Ltd India GLIMEPIRIDE glimepiride TABLET;ORAL 091220-006 Jun 29, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Micro Labs Ltd India GLIMEPIRIDE glimepiride TABLET;ORAL 091220-002 Jun 29, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Accord Hlthcare GLIMEPIRIDE glimepiride TABLET;ORAL 078181-001 Aug 23, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
UBS
Express Scripts
Cerilliant
Accenture
Colorcon
Fish and Richardson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot